Dr Madhukar Mittal Medical Endocrinology

Slides:



Advertisements
Similar presentations
Evaluating Thyroid Disorders ENT for the PA-C
Advertisements

Thyroid Disease M. Alhashash MD.
HYPERTHYROIDISM - Increased serum levels of thyroid hormones, - Surgical correction is frequently appropriate.
In the name of God Thyroid Benign Disease Nazila Abrishami June 2012.
WHO SHOULD BE TESTED FOR THYROID DYSFUNCTION? Groups with an increased likelihood of thyroid dysfunction Previous thyroid disease or surgery Goitre.
Stanley A. Tan MD, MS, MPH, PhD, DTM&H, FACE, FACC, FCCP
APPROACH TO A CASE OF THYROID NODULE
Thyroid nodules - medical and surgical management JRE DavisNR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary.
Neck Swelling Differential Diagnosis
Radiology of Thyroid and parathyroid
Head and Neck Conditions
Update in the Management of Thyroid Neoplasms University of Washington
Neck and Thyroid Surgeries
Iodine Deficiency Goiter
Hyperthyroidism Hypothyroidism Dr. Meg-angela Christi Amores.
Terry Kotrla, MS, MT(ASCP)BB
GOITER.
THYROID GLAND Begashaw M (MD). Anatomy Anatomy.
Radioiodine Therapy for Graves’ Disease Dr. Khalid B. Makhdomi Nuclear Medicine Physician Aga Khan University Hospital, Nairobi.
THYROID GLAND.
Thyroid Examination Wail Alamoudi. General examination Local examination.
ד"ר חגי מזא"ה כירורגיה אנדוקרינית מבואות כירורגיה שנה ד'
Thyroid Cancer.
Hyperthyroidism Hyperthyroidism is predominantly a disorder in women.
Approach to a thyroid nodule
THYROID GLAND Chloe Benner and Michelle Olson. LOCATION Situated in the anterior part of the neck “Adams’ apple” Originates in the back of the tongue.
Abdallah Al Marzouki, M.D. A 37 year old previously healthy woman presents to your clinic for unintentional weight loss. Over the past 3 months, she.
Approach to the Thyroid Nodule
Thyroid and Parathyroid diseases Surgical Approach Dr Mohammad AlShehri, Can. Board, FACS, D Med Edu. Professor of Surgery.
Management of the Thyroid Nodule Neil S Tolley MD FRCS DLO St Mary’s Hospital 28 th February 2002.
Thyroid Gland. - The first endocrine gland to develop. - Endodermal origin. - Originates from the ventral embryologic digestive tract. - midline diverticulum.
Thyroid Nodules Hollis Moye Ray, MD SEAHEC Internal Medicine June 3, 2011.
Managing a swelling in the thyroid Mark Lansdown Leeds Teaching Hospitals Trust.
For Papillary Carcinoma Surgical treatment Radioactive therapy Hormone therapy Chemotherapy.
 Previous batches recommended to read the Examination from browse starting from page 270,especially the special test of thyroid, and the examination of.
IMAGING OF THE THYROID Dr Jill Hunt Consultant Radiologist West Herts NHS Trust.
2.What do you think were the serum T3,T4, and TSH levels in the previous consult? What do you call this condition? – Normal levels of T3, T4 and TSH levels.
Evaluation of Thyroid Nodules
Primary hyperparathyroidism Surgical Approach Dr Mohammad AlShehri, Can. Board, FACS, D Med Edu. Professor of Surgery.
NECK MASSES.
Hyperthyroidism Clinical Applications Gail Nunlee-Bland, M.D. Division of Endocrinology.
Embryology & surgical anatomy The thyroglossal duct develops from the median bud of the pharynx. The foramen caecum at the base of the tongue is the vestigial.
Case scenarios- Neck Swelling
 The thyroid (Greek thyreos, shield, plus eidos, form) consists of two lobes connected by isthmus  Anterior to the trachea between the cricoid cartilage.
Question No.1 If you were the physician who initially saw the patient four years ago, what would you have done?
Anterior Neck Mass Case 1 Navarro – Ng 3-C. HISTORY OF PRESENT ILLNESS: – 7 Years Ago She noted an enlarging left anterior neck mass – 1 Year Ago Easy.
1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.
General Surgery Mosul university- College of dentistry-oral & maxillofacial surgery department Dr. Ziad H. Delemi B.D.S, F.I.B.M.S (M.F.) Neck lesions.
Thyroid disease By Dr Fahad.
Hypo,Hyperthyroidism and Hashimoto Thyroiditis Pathology.
NUCLEAR ENDOCRINOLOGY Thyroid
Neck mass. Cervical triangle Med line neck swelling  a-solid  1-submandibular LN enlargement  2-nodule in the isthmus of thyroid gland  b-cystic.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 66 Care of Patients with Problems of the Thyroid and Parathyroid Glands.
Topic : Diagnosis And Treatment Of Thyroid Disorders Using Radioisotopes by :Abdulrahman Moh’d Moh’d Khair Msc in Radiology Najran University Radiology.
What is your clinical impression? What are the differential diagnosis?
Thyroiditis refers to several disorders that cause an inflammation of the thyroid, a gland located in the front of your neck below your Adam's apple. The.
Primary hyperparathyroidism Surgical Approach Dr Mohammad AlShehri, Can. Board, FACS, D Med Edu. Professor of Surgery.

Dr Andrew S Bates Heart of England Foundation Trust
Dr. Amit Gupta Associate Professor Dept of Surgery
Radiology of Thyroid and parathyroid
COmmon Neck swellings Dr Mohammad AlShehri, Can. Board, FACS, D Med Edu. Professor of Surgery.
NECK MASSES.
Thyroid History + Examination
Thyroid Disorders Hussam AlHawari, MD, FACE, ECNU
Solitary Thyroid Nodule Aisha Abu Rashed
Solitary thyroid nodule approach
Thyroid disorders Dr Enas Abusalim.
Presentation transcript:

Dr Madhukar Mittal Medical Endocrinology Nontoxic goitre Dr Madhukar Mittal Medical Endocrinology

Goitre Solitary Nodular Multinodular Toxic Nontoxic Diffuse

Goitre Solitary Nodular Multinodular Diffuse Nontoxic Benign Malignant (20%) Multinodular Benign vs Malignant Diffuse Toxic Graves Simple autoimmune

Painful thyroid swelling Subacute thyroiditis Acute thyroiditis Invasive malignancy Amiodarone induced thyrotoxicosis, type 1

Hard thyroid swelling Reidel’s thyroiditis Thyroid carcinoma (firm : medullary CA, lymphoma)

Thyroid examination From behind with neck flexed slightly forward Rt lobe is 25% larger than left lobe Palpable and smooth normally

Midline neck swellings Goitre of thyroid isthmus & pyramidal lobe Thyroglossal cyst Suprasternal LN, lipoma Ludwig’s angina Submental LN Sublingual dermoid, lipoma

Lateral neck swellings Carotid triangle Thyroid Branchial cyst Carotid body tumor Carotid artery aneurysm Submandibular triangle LN Enlarged submandibular salivary gland Post triangle Cystic hygroma Pharyngeal pouch Subclavian aneurysm Cervical rib

Thyroid 12-20g Between cricoid cartilage & suprasternal notch Develops during 3rd week of GA from floor of primitive pharynx Hormone synthesis begins at 11 weeks GA Parathyroid glands located in posterior region of each pole of thyroid C cells : interspersed throughout thyrod gland

Thyroid examination Normally Pizillo’s method On swallowing Hands clasped behind head and push On swallowing Thyroid moves up Thyroglossal cysts Subhyoid bursitis Fixed prelaryngeal/pretracheal LN For retrosternal goitre Raise both arms till they touch ears Pemberton’s sign

Thyroid examination From behind with neck flexed Lahey’s method With both hands Crile’s method With thumb Kocher’s test Slight push on lat lobes produces stridor To exclude retrosternal prolongation

History Age Residence Pain Sleep Compressive symp Others Family H/O Young – colloid goitre, STN Middle age – hashimoto’s, follicular CA Residence Pain Sleep Compressive symp Others Respiratory Myopathy Cardiac Neurologic Family H/O

Examination Anemia BP Pulse rate Skin of hands (moist, hot/cold) Tremors – hand, tongue LN Facies Eye signs Dermopathy Acropachy Vitiligo

Malignancy Hard swelling Local signs LN – papillary, anaplastic Dyspnea, dysphagia, hoarseness of voice Carotid pulsations cannot be felt LN – papillary, anaplastic Metastases – follicular (bone, lungs) Recent increase in size of swelling with pain Diarrhea – medullary CA Prior h/o irradiation STN Male Solid nodule Large nodule >4cm Cold nodule (least imp sign)

Treatment

Hyperthyroidism of Graves disease Hypothyroidism Levothyroxine Hyperthyroidism of Graves disease Antithyroid drugs (Europe, Japan) Radioiodine (USA)

Acute thyroiditis Antibiotics Drainage of abscess

Subacute thyroiditis Aspirin – large doses 600mg 4-6 hrly Prednisolone 40-60 mg/d Thyrotoxic phase – β-blockers Hypothyroid phase – low dose levothyroxine

Silent thyroiditis Thyrotoxic phase – propranolol 20-40mg TDS/QID Hypothyroid phase – LT4 for 6-9 months Annual followup for permanent hypothyroidism

Reidel’s thyroidits Surgery + tamoxifen

Amiodarone induced Hypothyroidism Thyrotoxicosis type 1 LT4 Thyrotoxicosis type 1 Stop amiodarone if possible High doses of ATD Thyrotoxicosis type 2 Oral contrast agents (Na ipodoate, Na tyropanoate) K perchlorate Glucocorticoids Lithium Near total thyroidectomy

Simple goitre I2 or suppressive thyroxine therapy (young patients with soft goitre for 3-6 months) Radioiodine (decreases goitre size by 50%) Sx – for tracheal compression

MNG - toxic Sx Radioiodine in elderly Antithyroid drugs – often stimulate growth of goitre

MNG nontoxic Radioiodine Sx T4 suppressive therapy (rarely effective for decreasing goitre size)

Thyroid Cancer Lymphoma MTC Follicular Papillary External radiation Total thyroidecctomy Follicular Near total thyroidectomy f/b radioiodine & LT4 suppression Papillary Stage 1 – Sx f/b LT4 suppression Neck dissection only if LN involved

STN Hyperfunctioning Radioiodine ablation – esp >45yr Sx resection – esp <45yr Enucleation Lobectomy Ethanol injection

STN Examination / USG → MNG / STN TSH if low → thyroid scan → hot nodule – RAIA /Sx FNAC ← cold or indeterminate (if <1cm/difficult, then USG guided FNAC) FNAC report

FNAC report Benign Cyst Suspicious or malignant (10%) NonDx (20%) Suppressive therapy with LT4 for 6-12 months (30% decrease in size) Monitor by USG (Sx if increase in size or suspicious cytology) Cyst Reaspirate and follow by USG Suspicious or malignant (10%) Sx NonDx (20%) Repeat FNA

MNG

Nontoxic MNG Occurs in up to 12% of adults More common in females Increased prevalence with age More common in iodine deficient regions Most nodules are polyclonal in origin

Risk Factors Iodine deficiency Radiation exposure Exposure to iodine from contrast dyes or other sources may precipitate or exacerbate thyrotoxicosis in MNG

Etiology Pathogenesis of MNG is multifactorial. Genetic Autoimmune Environmental Major difference between toxic and nontoxic MNG Toxic MNG evolves from nontoxic MNG as part of the natural history of the disease Stages of nodular transformation of the thyroid Goitrogenic stimuli (iodine deficiency, autoimmunity, or nutritional goitrogens) cause diffuse thyroid hyperplasia In the proliferating thyroid, growth factor expression is increased, stimulating cellular division and formation of independent clones Most nodules in MNG are polyclonal in origin, but monoclonal nodules also occur

Diagnosis Detection of MNG by physical examination depends on goiter and nodule size, location, and anatomy of the patient’s neck Laboratory evaluation Determination of serum TSH will distinguish nontoxic MNG from toxic MNG Diagnostic imaging is indicated in following situations: To verify hyperfunctioning nodules in a patient with a MNG and concomitant clinical and/or laboratory evidence of hyperthyroidism To evaluate the degree of obstruction in large MNG Fine-needle aspiration (FNA) biopsy A dominant or enlarging nodule within MNG Nonfunctioning (cold) nodules ≥1–1.5 cm in diameter Nodules found to have microcalcifications, hypoechogenicity, complex architecture, or increased vascularity on ultrasonography FNA should not be used to evaluate autonomous (warm/hot) nodules

Imaging X-ray, CT, or MRI of the neck/chest indicated only when necessary for: Goiter anatomy Substernal extension Extent of tracheal compression Iodinated contrast agents should be administered cautiously to persons with a low TSH level May precipitate or exacerbate underlying hyperthyroidism Consider pretreatment with antithyroid drug therapy before imaging with contrast agents

Imaging Thyroid scintigraphy (123iodine or 99mtechnetium) Limited to patients with a low TSH level to verify the clinical diagnosis of toxic MNG Unnecessary in the setting of a normal TSH level. Toxic MNG shows heterogeneous iodine uptake with multiple regions of increased and decreased uptake Ultrasonography Recommended for all patients with known or suspected thyroid nodules Useful for accurate monitoring of nodule size or for guiding FNA biopsy of suspicious nodules

Endemic goitre More common in mountainous regions Diffuse goitre caused by I2 deficiency affecting >5% of population comprising children

Thank You

Iodine Deficiency

Iodine Deficiency Iodine is an essential micronutrient T4 synthesis Brain growth and development Daily requirement (adult) 150 ug/day 1 teaspoonful of iodine is sufficient for lifetime Iodine deficiency causes a wide spectrum of illness collectively termed iodine deficiency disorders (IDD) Iodine is an essential micronutrient required for synthesis of thyroid hormone, normal brain growth and development, maintenance of metabolism and thermo regulation

IDD: clinical spectrum Goiter (all ages) Primary hypothyroidism Cretinism Neurological Myxoedematous Mixed Learning disability Goiter and Cretinism

IDD Mild iodine deficiency causes, in children, poor school performance, reduced intellectual ability and impaired work capacity1,2 Results Compromised human potential Poor socio-economic development On a worldwide basis, iodine deficiency is the single most important preventable cause of brain damage This not only compromises the human potential but also results in poor socio-economic development of populations residing in endemic iodine deficient areas Tiwari BD, Godbole MM, et al. Learning disabilities and poor motivation to achieve due to prolonged iodine deficiency. Am J Clin Nutr 1996;63:782– 6. Kochupillai N., The impact of iodine deficiency on human resource development. Prog Food Nutr Sci. 1989;13(1):1-15. Review.

IDD: Causes Low dietary iodine contents Soil with low iodine content due to past glaciations or the repeated leaching effects of snow, water (floods) and heavy rainfall Crops grown in this soil, therefore, do not provide adequate amounts of iodine when consumed Iodine deficiency disorders (IDD) continue to be the major nutritional deficiency disorders throughout India

Global magnitude of IDD WHO data: IDD is a public health problem in 130 of 191 countries, Data insufficient to categorize 41 Only 20 countries free from IDD Globally, 740 million people with goiter, 13% of world’s population Over 2 billion people are exposed to the risk of IDD 35.2% of populations with urinary iodine excretion (UIE)< 100 µg/L

Global picture of IDD WHO Global Database on IDD

Magnitude of iodine deficiency - India Total districts in india: 587 321 districts surveyed 260 (81%) districts endemic for IDD 200 million people are at risk 71 million with goiter >8 million have neurological deficit National Iodine Deficiency Disorders Control Program: National Health Program Series 5. Published by Department of Communication, National Institute of Health and Family Welfare, New Delhi, 2003; 99. 

IDD: National Health Problem IDD is still a significant public health problem in India As per recommendation of Central Council of Health (1984), the GOI took policy decision for “Universal Iodization of Salt” to be achieved by year 1992. UP: USI started 2 Oct, 1987 Realizing the importance of iodine deficiency in relation to human resource development, National IDD Control Program has been included in 20-point program of prime minister

Shift in policies in salt iodination 1992: sale of non-iodized salt declared as punishable offence 2000: Punitive clause removed through Central notification 2005, Nov: Punitive clause restored

Non-uniform Iodized salt distribution in India The use of iodized salt varies dramatically from one state to another Why: number of factors scale of salt production, transportation requirements, enforcement efforts, differences in state regulations, the pricing structure, and storage patterns Adequately iodized salt is uniformly high (>72 %) in Northeast Region, in most states in the North region, and in Kerala, reaching a high of 94 percent in Manipur Lowest (<40%) in AP, MP, UP and Orissa

Presence of iodized salt in household Background characteristic None (0 ppm) Inadequate (<15 ppm) Adequate* (15+ ppm) India Urban 12.8 15.7 71.5 Rural 29.3 29.5 41.2 Uttar Pradesh 23.4 40.2 36.4 Numbers expressed as % *Adequate iodine contents in salt >15ppm National Family Health Survey 3 (NFHS-3), 2005-06

IDD: Epidemiological criteria Iodine Deficiency None Mild Moderate Severe Median urine iodine, µg/L >100 50-99 20-49 <20 Goiter prevalence <5% 5-20% 20-30% >30% Neonatal TSH,     >5 IU/L whole blood <3% 3-20% 20-40% >40% Cretinism +

Goitrogens Environmental Drugs Cassava root (contains thiocyanate) Cegetables cruciferae family (cabbage, cauliflower, brussel sprouts) Milk from regions where goitrogens are present in grass Others Drugs Iodides Amiodarone, aminoglutethemide, Lithium Cobalt Diiodoquinone Ethionamide PAS